Clearing clinical and regulatory hurdles in the development of a fast-acting nasal spray for a heart condition has been a ...

The regular arrhythmia occurring at the beginning of the electrocardiogram was identified as ventricular bigeminy. Single ventricular premature complexes (VPCs), as well as pairs and triplets of ...

[Joglar JA, et al. J Am Coll Cardiol. 2023;17a] Paroxysmal AF is self-limiting; restoration of sinus rhythm occurs spontaneously. By definition, paroxysmal AF lasts for less than 7 days (usually ...

Milestone in 2023 agreed to sell a royalty interest in etripamil to RTW Investments for $75 million, subject to the company receiving FDA approval of the drug by the end of September 2025. Write to ...

Paroxysmal atrial fibrillation: Self-limiting and sinus rhythm restores spontaneously. Lasts for less than 7 days. Does not require intervention to convert to a normal rhythm (electrical or ...

while sinus rhythm maintenance was remarkably higher in the ABL group at the end of follow-up (83.7% vs 21.1% in PM group, P < 0.001). Conclusions: In patients with paroxysmal AF-related ...

Max recommended dose for paroxysmal supraventricular arrhythmias is 300mg/day. Sustained ventricular tachycardia (VT): 100mg every 12 hours; may be increased in increments of 50mg twice daily ...